Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
37.36
-2.36 (-5.94%)
At close: Mar 31, 2025, 4:00 PM
36.00
-1.36 (-3.64%)
After-hours: Mar 31, 2025, 6:40 PM EDT

Apogee Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Apogee Therapeutics stock have an average target of 91.33, with a low estimate of 89 and a high estimate of 95. The average target predicts an increase of 144.46% from the current stock price of 37.36.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $89 $91.33 $90 $95
Change +138.22% +144.46% +140.90% +154.28%

Analyst Ratings

The average analyst rating for Apogee Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 455543
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 566654

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Buy
Initiates
$95
Strong Buy Initiates $95 +154.28% Mar 13, 2025
Guggenheim
Guggenheim
Strong Buy
Reiterates
n/a
Strong Buy Reiterates n/a n/a Feb 10, 2025
Guggenheim
Guggenheim
Strong Buy
Reiterates
n/a
Strong Buy Reiterates n/a n/a Dec 12, 2024
Guggenheim
Guggenheim
Strong Buy
Reiterates
$95$110
Strong Buy Reiterates $95$110 +194.43% Dec 3, 2024
Wedbush
Wedbush
Buy
Maintains
$87$90
Buy Maintains $87$90 +140.90% Dec 2, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
25.50M
Revenue Next Year
228.29M
from 25.50M
Increased by 795.25%
EPS This Year
-5.12
from -3.30
EPS Next Year
-6.14
from -5.12
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
---25.50M228.29M
Revenue Growth
----795.25%---
EPS
-17.63-3.36-3.30-5.12-6.14-6.60-6.50-6.17
EPS Growth
--------
Forward PE
--------
No. Analysts ---1110843
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20252026202720282029
High -3.70 -4.55 -4.85
Avg -5.12 -6.14 -6.60
Low -6.80 -10.44 -10.97

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.